This is the most comprehensive review to date of longterm cardiovascular outcome trials for GLP1 receptor agonists, lead author Simon Cork said in a press release
Abilify Use Depression, bipolar disorder Warning Suicidal thoughts in youth, death risk in elderly with dementia-related psychosis Accutane Use Severe acne Warning Birth defects Actos Use Type 2 diabetes Warning Heart failure risk Avandia Use Type 2 diabetes Warning Congestive heart failure Benicar Use High blood pressure Warning Fetal toxicity Cipro, Levaquin and Avelox Use Antibiotics Warning Tendon rupture, peripheral neuropathy, central nervous system effects Cymbalta Use Depression, anxiety Warning Suicide risk Depakote Use Epilepsy Warning Birth defects, liver toxicity, pancreatitis Essure Use Birth control Warning Perforation of the uterus and/or fallopian tubes, pain, allergic reactions, device migration Invokamet, Janumet, Kazano Use Type 2 diabetes Warning Lactic acidosis related to the metformin component Power Morcellators Use Fibroids Warning Risk of spreading uterine cancer SSRIs and SNRIs Use Depression, anxiety Warning Suicide risk in children Testosterone Use Hypogonadism Warning Exposure to women, children Risperdal Use Schizophrenia, bipolar disorder Warning Death risk in elderly with dementia-related psychosis Issues with Boxed Warnings The boxed warning has been the FDAs go-to for flagging dangerous drugs
The aesthetic side effects of GLP-1 weight loss are real and they're very treatable when approached with the right protocol and timing
In addition, be especially cautious of preservatives like sodium benzoate, sorbic acid, BHA, and BHT
